Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.2160
-0.0010 (-0.46%)
Streaming Delayed Price
Updated: 3:55 PM EDT, May 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cns Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Researchers Want to Manage Cancer By Keeping Malignant Cells Restricted in Place
August 12, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success
August 12, 2022
Via
Investor Brand Network
Exposures
Product Safety
Study Finds That Ketogenic Diet May Help Patients with Brain Cancer
August 04, 2022
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advances Drug Candidate to Fight Aggressive Brain Cancer Amid Difficult Era for Market
August 04, 2022
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expanding Scope of Potentially Pivotal Study as Part of Clinical Program to Develop GBM Treatment
August 02, 2022
Via
Investor Brand Network
Study Suggests That Test of Memory May Signal Brain Tumor Presence
July 07, 2022
Via
Investor Brand Network
Symptoms of Brain Tumors To Watch For
June 15, 2022
Via
Investor Brand Network
Researchers Develop Blood Test to Improve Tumor Diagnosis, Monitoring
July 27, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Urges Shareholders to Vote in Favor of Proxy Proposals for Upcoming Annual Meeting
July 25, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Expanding Patient Eligibility in Potentially Pivotal Berubicin Trial
July 20, 2022
Via
Investor Brand Network
Preclinical Study Uncovers Potential Key to Treating Deadly Brain Tumors
July 18, 2022
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment
July 11, 2022
Via
Investor Brand Network
Exposures
Product Safety
AI May Help Improve Brain Cancer Diagnosis
June 29, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial
June 23, 2022
Via
Investor Brand Network
Exposures
Product Safety
Study Suggests Healthcare Workers Don’t Know Enough About Childhood Brain Tumors
June 22, 2022
Via
Investor Brand Network
Study Finds That Brain Tumors May Originate from Different Site
June 08, 2022
Via
Investor Brand Network
Exposure to Wildfires Amplifies Cancer Risk, New Study Finds
June 01, 2022
Via
Investor Brand Network
Genomic Sequencing Offers Hope in Diagnosis, Treatment of Brain Tumors
May 24, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright Global Investment Conference
May 24, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Among Most Powerful of Chemotherapy Drugs
May 23, 2022
Via
Investor Brand Network
Lantern Pharma to Host Glioblastoma Multiforme Webinar to Mark Brain Tumor Awareness Month
May 19, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract to be Presented at American Society of Clinical Oncology 2022 Annual Meeting
May 18, 2022
Via
Investor Brand Network
Updated Guidelines Shed Light on Using Radiation Against Brain Metastases
May 16, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2022 Financial, Corporate Update
May 16, 2022
Via
Investor Brand Network
Exposures
Product Safety
Researchers Develop Models to Better Understand Brain Cancer Metastasis
May 11, 2022
Via
Investor Brand Network
Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)
May 11, 2022
Via
Investor Brand Network
Study Finds Strong Link Between Hormone Drug, Growth of Brain Tumors
May 06, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’
May 05, 2022
Via
Investor Brand Network
Johns Hopkins Researchers Receive Millions for New Cancer Research Projects
May 03, 2022
Via
Investor Brand Network
Researchers May Have Found New Way to Slow Progression of Cancer
May 02, 2022
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.